Also known as: Exendin-4
Exenatide is a synthetic peptide that mimics the action of the incretin hormone GLP-1 (glucagon-like peptide-1). Classified under fat loss and metabolic peptides, it is primarily utilized in research to explore the incretin pathway, which plays a crucial role in glucose metabolism and appetite regulation. Originally developed for the treatment of type 2 diabetes, Exenatide has garnered attention for its potential applications in metabolic studies.
Exenatide functions by binding to GLP-1 receptors, stimulating insulin secretion in response to elevated blood glucose levels. This action not only promotes insulin release but also inhibits glucagon secretion, leading to a reduction in hepatic glucose production. Additionally, Exenatide slows gastric emptying, which contributes to increased satiety and reduced food intake.
Exenatide serves as a valuable research tool in the study of the incretin pathway, particularly in the context of metabolic health and weight management. Its mechanisms of action highlight its potential in regulating glucose levels and appetite, making it a significant peptide in metabolic research.
Last updated: Feb 25, 2026